Seth Loring Harrison Akero Therapeutics, Inc. (AKRO) insider trading activity

Seth Loring Harrison is of Akero Therapeutics, Inc.. Currently has a direct ownership of 145,699 shares of AKRO, which is worth approximately $7.98 Million. The most recent transaction as insider was on Jun 03, 2025, when has been sold 9,398 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K

6.9% 3M change

6.9% 12M change

Total Value Held $7.98 Million

Seth Loring Harrison Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2025	BUY Grant, award, or other acquisition	-	9,398 Added 6.06%	145,699 Common Stock
Nov 30 2022	SELL Open market or private sale	$521,969 $47.02 p/Share	11,101 Reduced 7.53%	136,301 Common Stock
Oct 28 2022	SELL Open market or private sale	$860,316 $40.7 p/Share	21,138 Reduced 12.54%	147,402 Common Stock
Oct 27 2022	SELL Open market or private sale	$2,798,527 $42.13 p/Share	66,426 Reduced 28.27%	168,540 Common Stock
Oct 26 2022	SELL Open market or private sale	$2,897,622 $43.98 p/Share	65,885 Reduced 21.9%	234,966 Common Stock
Oct 25 2022	SELL Open market or private sale	$202,814 $44.92 p/Share	4,515 Reduced 1.48%	300,851 Common Stock

Also insider at

STOK

Stoke Therapeutics, Inc. Healthcare

SLH